APP下载

对1例西妥昔单抗所致痤疮样皮疹患者的药学监护

2020-07-31杨慧李亚南席骏钻沈锦华

上海医药 2020年13期

杨慧 李亚南 席骏钻 沈锦华

摘 要 目的:探索临床药师对使用抗肿瘤靶向药物治疗患者实施药学监护的方法和意义。方法:临床药师参与1例直肠癌患者使用西妥昔单抗联合化疗的治疗过程,探究导致患者出现痤疮样皮疹的可能原因,提出治疗方案并监护用药治疗全过程。结果:通过有效的干预和全面的药学监护,患者皮疹得到有效控制。结论:临床药师对肿瘤患者实施药学监护可有效减轻抗肿瘤靶向药物治疗的不良反应,提高临床抗肿瘤治疗水平,保障肿瘤患者的用药安全。

关键词 西妥昔单抗 痤疮样皮疹 临床药师 药学监护

中图分类号:R979.19 文献标志码:C 文章编号:1006-1533(2020)13-0060-03

Pharmaceutical care for a patient with acneiform rash caused by cetuximab

YANG Hui*, LI Yanan, XI Junzuan, SHEN Jinhua

(Department of Pharmacy, the Peoples Hospital of Rugao, Jiangsu Nantong 226500, China)

ABSTRACT Objective: To investigate the methods and significance of clinical pharmacists in the implementation of pharmaceutical care for a patient treated with anti-tumor targeted drugs. Methods: Clinical pharmacists participated in the whole treatment process of cetuximab combined with chemotherapy in the patient with rectal cancer, explored the possible causes of acneiform rash, proposed a therapeutic regimen and monitored the whole process of medication. Results: The acneiform rash of the patient was effectively controlled by effective intervention and comprehensive pharmaceutical care. Conclusion: The adverse reactions caused by anti-tumor targeted drug can be effectively reduced, the clinical anti-tumor treatment level can be improved and the safety of cancer patients can be ensured by clinical pharmacists in the implementation of pharmaceutical care.

KEy WORDS cetuximab; acneiform rash; clinical pharmacists; pharmaceutical care

结直肠癌是临床上最常见的消化道恶性肿瘤之一[1]。目前,国内外的结直肠癌诊疗指南[2]均推荐西妥昔单抗联合由奥沙利铂、氟尿嘧啶、亞叶酸钙组成的FOLFOX方案,或由奥沙利铂、卡培他滨组成的XELOX方案,或由伊立替康、氟尿嘧啶、亚叶酸钙组成的FOLFIRI方案为KRAS野生型的转移性结直肠癌患者的一线治疗方案。研究表明,西妥昔单抗联合化疗治疗KRAS野生型的转移性结直肠癌患者不仅可显著提高治疗效果,且还能显著延长患者的疾病无进展生存期和总生存期[3]。西妥昔单抗治疗的最常见不良反应是皮肤反应,表现为痤疮样皮疹、瘙痒和指甲变化[4]。本文报告对1例使用西妥昔单抗联合化疗治疗后出现严重痤疮样皮疹的晚期直肠癌患者的药学监护过程及其结果,旨在为临床安全使用抗肿瘤靶向药物提供参考。……

登录APP查看全文